HYTN Broadens Reach with Innovative Cannabis-Infused Nano Shot
VANCOUVER, British Columbia, Feb. 20, 2024 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN “HYTN or The Company“), a leader in the cannabis sector known for specialized psychoactive and psychotropic product development, is excited to announce the expansion of its 100 mg Nano Shot Citrus (“Nano Shot”) to the key markets of British Columbia and Alberta. Following its initial success in Ontario, Canada’s largest market, this move represents a significant stride in the company’s national distribution goals.
Related news for (HYTNF)
- HYTN Completes Acquisition of Prism Scientific Labs, Enhancing Psychedelic Compound Manufacturing Capabilities
- HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities
- HYTN Welcomes U.S. Recommendation to Reclassify Cannabis, Foresees Growth
- HYTN Innovates GMP Stability Programs, Sets Industry Benchmark
- HYTN Welcomes Health Canada for Audit to Enhance GMP Capabilities